Skip to content
Monday, March 30, 2026

TrialistMD

Clarity in Trials, Confidence in Decisions

  • Home
  • Clinical trials
    • Dermatology
    • Rare disease
    • Cardiology
    • Metabolic
    • Nephrology
    • Oncology
      • Breast
      • Gastrointestinal
      • Head and Neck Carcinoma
      • Hepatic
      • Lung Carcinoma
      • Renal Carcinoma
      • Genitourinary
  • FDA Approved Drugs
    • 2021 Approval
    • 2022 Approval
    • 2023 Approval
    • 2024 Approval
    • 2025 Approval
    • 2026 Approval
  • About us
  • 📞 Contact Us
You are Here
  • Home
  • Clinical trials
  • Rare disease

Category: Rare disease

Rare disease

NAVEPEGRITIDE

March 22, 2026March 29, 2026

NAVEPEGRITIDE (YUVIWEL) Navepegritide (YUVIWEL) is a once-weekly subcutaneous injection designed to enhance linear growth in pediatric patients aged two and

  • 📞 Contact Us
  • About us
  • Privacy
All Rights Reserved 2026.
Proudly powered by WordPress | Theme: Nhuja News by Candid Themes.